Consumption of psychotropics at the Sayago Health Centre

  • Graciela García Universidad de la República, Facultad de Medicina, Instituto de Higiene, Departamento de Medicina Preventiva y Social, Asistente
  • Julio Vignolo Universidad de la República, Facultad de Medicina, Instituto de Higiene, Departamento de Medicina Preventiva y Social, Asistente
  • Myriam Contera Universidad de la República, Facultad de Medicina, Instituto de Higiene, Departamento de Medicina Preventiva y Social, Prof. Agregada
  • Nelly Murillo Universidad de la República, Facultad de Medicina, Instituto de Higiene, Departamento de Medicina Preventiva y Social, Profesora
Keywords: PSYCHOTROPICS, PRESCRIPTION OF MEDICINES, PRIMARY HEALTH CARE, ADULT, ELDERLY

Abstract

The objective of the present work was to address the distribution of psychotropics intake by a population composed of 91 persons that were 65 years old or older, all users of the Sayago Health Centre. A transversal descriptive study was performed between June to September of 1998 and specifically designed tools were used such as the test of Cage and the Self Reporting Questionnaire (SRQ) test.
Monthly, annual and life prevalence of psychotropics intake was 67%, 75%, and 81% respectively. Monthly prevalence of psychotropic consumption between women was higher than between men. 96% of the whole population did not exhibit alcohol-dependence, measured by the Test of Cage. 56% of the whole of consumers of minor tranquillizers during the last month carried minor psychiatric disorders. It was found that 85% of the total of consumers used psychotropics for at least a year. Prescription was decided by general practitioners in 95% of all cases. The drug that was most frequently prescribed was diazepam representing 52% of all prescriptions.

References

1) Murray J, Dunn G, Williams P, Tarnoplsky. A factors affecting the consumption of pshychotropic drugs. Psychological Medicine, 1981; 11: 551-60.
2) Algulander C. History and current status of sedative-hypnotic drug use and abuse. Acta Psychiatrica Scandinavica, 1986; 73: 465-78.
3) Balter MB, Mannheimer D. A cross-national comparison of anti-anxiety/sedative drug use. Current Research and Opinion, 1984; 8(suppl 4): 5-20.
4) Busto MA. "BDZ", la tranquila adicción de Santiago. Interamericana. Santiago; 1991.
5) Tancredi F. Aspectos epidemiológicos do consumo de medicamentos psicotrópicos pela populaçao de adultos de distrito de São Paulo. São Paulo, Tesis de Mestrado, Universidad de San Pablo, Facultad de Medicina, 1979.
6) Rey A, Gutiérrez S, Moulia M. Análisis de las prescripciones médicas en una institución de salud. Congreso Latinoamericano de Farmacología y Terapéutica, 13, Montevideo 1990.
7) Rey A, Gutiérrez S, Moulia M. Estudio sobre prescripción de psicofármacos en una Institución de Salud. Congreso Latinoamericano de Farmacología y Terapéutica, 13. Montevideo, 1990.
8) Bustelo P. Estudio de la prevalencia del consumo de tranquilizantes menores en la ciudad de Montevideo. Tesis de Doctorado presentada a la Escola Paulista de Medicina. San Pablo, 1994.
9) Marks J. The benzodiacepinas for good or evil. Neuropsychobiology 1983; 10(2-3): 115-26.
10) Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ. Psichotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316: 363-69.
11) Instituto Nacional de Estadística (Uruguay). VII Censo General de Población III de Hogares y V de Viviendas, Montevideo: INE, 1996; 1: 3-13.
12) Paparamborda MC. Informe de Fin de Siglo. Montevideo: MSP, 1999.
Published
2002-09-30
How to Cite
1.
García G, Vignolo J, Contera M, Murillo N. Consumption of psychotropics at the Sayago Health Centre. Rev. Méd. Urug. [Internet]. 2002Sep.30 [cited 2024Nov.17];18(2):154-60. Available from: http://www2.rmu.org.uy/ojsrmu311/index.php/rmu/article/view/990